The opportunity they have in front of them is Riyo.
Endorsements it has received to date suggests it is has a very sound future.
Plus there is no doubt add ons etc that can be incorporated.
JCurve should dismantle this monolithic agency business model and strike out on their own path. Do a deal with Netsuite to onsell the existing customer base.
Then find a collaborative partner/potential start or acquisition. They have been looking for years, surely they must have some proposals available.
They have over $4m in cash, a share registry of 327million shares. Top 20 hold 74% of the shares.
It also needs commercial experienced leadership to drive a new agenda.
The alternative is an accountant running a set of books to balance whilst being answerable to Netsuite.
Look at the investor interest in the existing business model. Pathetic.
Shareholders in the top 20 shuffling shares amongst each other in hope.
- Forums
- ASX - By Stock
- JCS
- 20 years as an ASX listing.
JCS
jcurve solutions ltd
Add to My Watchlist
11.4%
!
3.1¢

20 years as an ASX listing., page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.1¢ |
Change
-0.004(11.4%) |
Mkt cap ! $11.56M |
Open | High | Low | Value | Volume |
3.1¢ | 3.1¢ | 3.1¢ | $536 | 17.30K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 81379 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 319735 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 81379 | 0.031 |
1 | 250000 | 0.030 |
1 | 160000 | 0.016 |
1 | 70000 | 0.014 |
1 | 80000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 319735 | 1 |
0.035 | 80000 | 1 |
0.036 | 1105808 | 1 |
0.048 | 297308 | 1 |
0.050 | 162000 | 1 |
Last trade - 10.42am 15/07/2025 (20 minute delay) ? |
Featured News
JCS (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
SPONSORED BY The Market Online